The impact of SARS-CoV-2 infection in children with rheumatic/autoinflammatory diseases on immunosuppressive treatment: a single centre experience

Affiliations

• ¹ Rheumatology Unit, Second Department of Paediatrics, "P. & A. Kyriakou" Children's Hospital, Medical School, National and Kapodistrian University of Athens (NKUA), Athens, Greece. dmaritsi@gmail.com.
• ² Infectious Diseases Unit, Second Department of Paediatrics, "P. & A. Kyriakou" Children's Hospital, Medical School, National and Kapodistrian University of Athens (NKUA), Athens, Greece.
• ³ Rheumatology Unit, Second Department of Paediatrics, "P. & A. Kyriakou" Children's Hospital, Medical School, National and Kapodistrian University of Athens (NKUA), and Neurology Unit, Second Department of Paediatrics, "P. & A. Kyriakou" Children's Hospital, School of Medicine, National and Kapodistrian University of Athens (NKUA), Athens, Greece.
• ⁴ Rheumatology Unit, Second Department of Paediatrics, "P. & A. Kyriakou" Children's Hospital, Medical School, National and Kapodistrian University of Athens (NKUA), Athens, Greece.
• ⁵ Rheumatology Unit, Second Department of Paediatrics, "P. & A. Kyriakou" Children's Hospital, Medical School, National and Kapodistrian University of Athens (NKUA), and Infectious Diseases Unit, Second Department of Paediatrics, "P. & A. Kyriakou" Children's Hospital, Medical School, National and Kapodistrian University of Athens (NKUA), Athens, Greece.